Skip to main content
. 2022 Oct 20;27(20):7097. doi: 10.3390/molecules27207097
BH Balancer-heterozygous individuals
DXR Doxorubicin
LD Lethal Dose
ETT Epithelial tumor test
FM Frequency of mutation
FR Frequency of recombination
HB High Bioactivation cross
LATS1 Large tumor suppressor kinase 1
MH Trans-heterozygous individuals
MTT 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide
PCa Prostate Cancer
ROS Reactive oxygen species
SI Selectivity Index
SMART Somatic Mutation and Recombination Test
SMN Subsequent malignant neoplasm
ST Standard cross
TX Toxicity Test